Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

NCT06267326 is registered in ClinicalTrials.gov with Nasser Institute For Research and Treatment as lead sponsor.

NCT NCT06267326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06267326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt
Lead sponsor
Nasser Institute For Research and Treatment
Phase
Phase 1/2
Overall status
Completed
Start date
May 23, 2021
Completion date
August 21, 2023
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, mucormycosis; rhinocerebral (etiology)